CytomX Therapeutics, LLC

Businessfiled

CytomX Therapeutics, LLC operates in Other, based in SANTA BARBARA.

Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

CytomX Therapeutics, LLC has raised $13M in disclosed capital across 8 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $2.7M on 2010-09-22.

Most recent recorded round closed around 2015-02-11.

Valuation (modeled)modeled

Provath models CytomX Therapeutics, LLC at approximately $28M (range $1.4M–$219M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.86× the median modeled value of Seed Other companies in 2013–2015 (998 peers) — value vs value, same stage and era. Within the normal band (86% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 10 months.

Last raise 11.4 yr ago; this sector typically re-raises about every 11 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 1.1× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 81% of Other peers (25015 compared).

Modeled value ranks above 61% of those peers.

Closest niche peers: Bodri Capital Management, LLC, as Trustee under that certain Declaration of Trust dated December 17, 2015, 76826774, Llc, 76826773, Llc, 76826772, Llc, EW Investor, LLC.

Peoplefiled

5 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Broad sector classification weakens peer comparison.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.